Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The pharmaceutical landscape is constantly evolving, driven by the pursuit of novel therapeutic agents that address unmet medical needs. In the realm of liver diseases and metabolic disorders, Obeticholic Acid (CAS 459789-99-2) has emerged as a compound of significant interest. As a potent and selective agonist of the Farnesoid X Receptor (FXR), it offers a unique mechanism for tackling complex health challenges.
Obeticholic Acid's primary mechanism of action involves the activation of FXR, a nuclear receptor that plays a central role in regulating bile acid metabolism, lipid homeostasis, and inflammation. This intricate signaling pathway is fundamental to liver health. The compound's established use in treating primary biliary cholangitis (PBC), a chronic liver disease, highlights its therapeutic efficacy. For researchers exploring the nuances of bile acid signaling and its impact on liver function, the opportunity to buy Obeticholic Acid is crucial for advancing their work.
A major focus of current research is the application of Obeticholic Acid in nonalcoholic steatohepatitis (NASH). NASH is a significant public health concern, characterized by liver inflammation and damage, often linked to metabolic syndrome. Obeticholic Acid's demonstrated ability to reduce liver fat, inflammation, and fibrosis in preclinical models positions it as a promising therapeutic candidate for NASH. The availability of high-quality obeticholic acid research chemical from suppliers like NINGBO INNO PHARMCHEM CO.,LTD. is vital for the successful execution of these critical studies.
The impact of Obeticholic Acid extends beyond NASH, with research also investigating its potential benefits in managing portal hypertension and bile acid diarrhea. Its influence on vascular resistance and bile acid absorption pathways opens up new avenues for therapeutic intervention in liver disease complications. The consistent demand for a reliable obeticholic acid pharmaceutical chemical underscores its importance in the R&D pipeline.
As the scientific community continues to unravel the multifaceted roles of FXR agonism, Obeticholic Acid remains at the forefront of pharmaceutical innovation. Its potent activity and diverse applications make it an indispensable tool for researchers. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting these efforts by providing Obeticholic Acid, enabling groundbreaking research that could lead to significant advancements in liver disease and metabolic health management.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
